Skip to main content
Log in

A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma

  • Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 3. Reservoir and Others
  • Hepatocellular Carcinoma, Chemotherapy, Liiodol
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

We conducted a prospective randomized trial to evaluate the efficacy of Lipiodol in intrahepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma (HCC). A total of 38 patients with unresectable HCCs and underlying cirrhosis were entered in this trial, and 36 of them were evaluable. Every 4 weeks, 17 patients received 70 mg of 4′-epidoxorubicin (epirubicin) alone (group A), whereas 19 patients received a Lipiodol emulsion containing the same dose of epirubicin (group B) through the hepatic artery. A tumor response (CR+PR) was observed in 12% of group A patients and in 42% of group B patients. The group B patients showed a significantly higher response rate than the group A patients. There was a tendency for an increased duration of survival (P=0.09) in the group B patients. These results suggested that the infusion of the Lipiodol emulsion with epirubicin was more effective than epirubicin alone for the treatment of these patients with HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chen HSG, Gross JF (1980) Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64: 31

    Google Scholar 

  2. Cho KJ, Andrews JC, Williams DM, Doenz F, Guy GE (1989) Hepatic arterial chemotherapy: role of angiography. Radiology 173: 783

    Google Scholar 

  3. Konno T (1992) Targeting chemotherapy for hepatoma: arterial administration of anticancer drugs dissolved in Lipiodol. Eur J Cancer 28: 403

    Google Scholar 

  4. Leung WT, Shiu WCT, Leung N, Chan M, Tao M, Li AKC, Metreweli C (1992) Treatment of inoperable hepatocellular carcinoma by intra-arterial Lipiodol and 4′-epidoxorubicin. Cancer Chemother Pharmacol 29: 401

    Google Scholar 

  5. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H, Hirohashi S (1987) Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 162: 345

    Google Scholar 

  6. Tamamoto M, Sugahara K (1992) Primary liver cancer in Japan. In: Overview of the general rules for the clinical and pathological study of primary liver cancer in Japan. Springer, Berlin Heidelberg New York Tokyo, p 385

    Google Scholar 

  7. Yoshikawa M, Ebara M, Nakano T, Minoyama A, Sugiura N, Ohto M (1992) Percutaneous transaxillary catheter insertion for hepatic artery infusion chemotherapy. AJR 158: 885

    Google Scholar 

  8. Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K, Okuda K (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154: 19

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshikawa, M., Saisho, H., Ebara, M. et al. A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother. Pharmacol. 33 (Suppl 1), S149–S152 (1994). https://doi.org/10.1007/BF00686689

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686689

Keywords

Navigation